GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Additional Paid-In Capital

Aptahem AB (XSAT:APTA) Additional Paid-In Capital : kr193.56 Mil(As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Additional Paid-In Capital?


Aptahem AB's quarterly additional paid-in capital declined from Sep. 2023 (kr183.18 Mil) to Dec. 2023 (kr151.31 Mil) but then increased from Dec. 2023 (kr151.31 Mil) to Mar. 2024 (kr193.56 Mil).

Aptahem AB's annual additional paid-in capital increased from Dec. 2021 (kr143.00 Mil) to Dec. 2022 (kr148.00 Mil) and increased from Dec. 2022 (kr148.00 Mil) to Dec. 2023 (kr151.31 Mil).

Aptahem AB Additional Paid-In Capital Historical Data

The historical data trend for Aptahem AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Additional Paid-In Capital Chart

Aptahem AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.05 35.22 143.00 148.00 151.31

Aptahem AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 178.77 184.90 183.18 151.31 193.56

Aptahem AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Aptahem AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB (XSAT:APTA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Additional Paid-In Capital
Comparable Companies
XSAT:DBP B OSTO:ONCOZ OSTO:2CUREX OSTO:CMOTEC B XSAT:CHOSA OSTO:MODTX OSTO:FLUI OSTO:LPGO OSTO:SCOL OSTO:EXPRS2 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Norra Vallgatan 58, Malmo, SWE, 211 22
Website
http://www.aptahem.com
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB (XSAT:APTA) Headlines

No Headlines